x
Marksman Healthcare
[contact-form-7 id="2459" title="Sidebar Form"]

  • Bulls Stadium, California
  • 666-888-0000
  • info@example.com
Marksman Healthcare
  • Home
  • About Us
  • Services
    • HEOR
    • RWE
    • Value Communications
    • Competitive Intelligence
  • Case studies
  • Publications
  • Key Highlights
  • Blog
  • MarksMan Academy
  • Contact Us
Marksman Healthcare
  • Contact Us
Logo

Contact Info

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • +91-9160467576
  • enquiry@marksmanhealthcare.com

Author: MarksMan Healthcare

    Marksman Healthcare > Articles by: MarksMan Healthcare

30May

Revolutionizing Healthcare With Internet-of Things (IOT)

by MarksMan Healthcare,  2 Comments

The “Internet of things” (IoT) is becoming an increasingly growing topic of conversation both in the workplace and outside of it. It’s a concept that not only has the potential […]

Read More

15May

Adaptive Licensing and Real World Evidence (RWE)

by MarksMan Healthcare,  0 Comments

We all want safe and effective medicines to reach patients as soon as possible, but as we know, drug development, market authorization and payer assessment are all slow sections of […]

Read More

26Apr

Facts & Fiction – Branded v/s Generic Controversy – India

by MarksMan Healthcare,  0 Comments

All branded drugs are of good quality – Fiction Majority of the branded drugs are of good quality – Fact All generic drugs are of good quality – Fiction Majority […]

Read More

25Apr

Is India Gearing up for Patient Centric Healthcare Model?

by MarksMan Healthcare,  0 Comments

Following the recent announcement by PM Narendra Modi hinting at a legal framework for doctors to prescribe generic medicines cheaper than equivalent branded generic drugs, doctors appeared to welcome the […]

Read More

10Apr

Whose Stent is it Anyway?

by MarksMan Healthcare,  0 Comments

Bioresorbable stents have effectively been pulled from the European market by Abbott and will now be available only in “clinical registry setting at select sites/institutions” in Europe, where they will […]

Read More

31Mar

Economic Burden of Counterfeit Medicines in India

by MarksMan Healthcare,  0 Comments

According to the World Health Organization (W.H.O), there is currently no universally agreed definition among its member states in what is widely known as ‘Counterfeit medicines’. Nevertheless, W.H.O does indicate […]

Read More

19Mar

Multi-Criteria Decision Analysis: A New Paradigm in Healthcare Decision Making

by MarksMan Healthcare,  0 Comments

Healthcare decision making is usually characterized by a low degree of transparency. The demand for transparent decision processes can be fulfilled only when assessment, appraisal and decisions about health technologies […]

Read More

06Mar

Database Use in Outcomes Research Studies

by MarksMan Healthcare,  0 Comments

Clinical research includes the traditional prospective clinical trials, cohort studies, and case-control studies, while outcomes research (OR) has now solidified itself as a separate class of clinical research. OR is […]

Read More

07Feb

Use of QALY in Healthcare Decision-Making – The Controversy Continues

by MarksMan Healthcare,  0 Comments

In many parts of the world, the value of medicines is measured by a unit called ‘Quality-Adjusted Life Year’ (QALY), a metric that health economists and others use to quantify […]

Read More

Posts navigation

1 … 11 12 13 14 15

Your Partner in Evidence
Synthesis and Market Access

Book Free Sampling Here

Latest Blogs

Quick links

Work with us

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • Call Us: +91-9160467576
  • enquiry@marksmanhealthcare.com

Using Synthetic Controls in Oncology Real-World Data Studies for Treatment Insights

September 20, 2023

Strategizing Optimal Collection and Use of Real-World Data from Expanded Access Programs

September 18, 2023

International Reference Pricing vs. Value-Based Pricing: Drug Pricing Strategies

September 11, 2023

  • About Us
  • Our Services
  • Case Studies
  • Publications
  • Careers
  • Contact Us
  • Policy

We believe that work is to be pursued and enjoyed through commitment, teamwork, creative thinking, and an ethical approach in everything we do. Apply HERE about openings

HEOR, RWE, and Market Access Consulting

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • Call Us: +91-9160467576
  • enquiry@marksmanhealthcare.com

Latest Blogs

Using Synthetic Controls in Oncology Real-World Data Studies for Treatment Insights

September 20, 2023

Strategizing Optimal Collection and Use of Real-World Data from Expanded Access Programs

September 18, 2023

International Reference Pricing vs. Value-Based Pricing: Drug Pricing Strategies

September 11, 2023

Quick links

  • About Us
  • Our Services
  • Case Studies
  • Publications
  • Careers
  • Contact Us
  • Policy

Work with us

We believe that work is to be pursued and enjoyed through commitment, teamwork, creative thinking, and an ethical approach in everything we do. Apply HERE about openings

Copyright © 2023 Marksman Healthcare Communications Crafted by LUBUS

 

Loading Comments...